SFBN Feed: The Endpoints 11 2024 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry https://lnkd.in/ggN_Cira What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We’ve spent the last several months examining dozens of finalists, talking to investors and biotech veterans to get their [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
San Francisco Biotech Networks
Biotechnology Research
Resource for bay area life scientists and biotech professionals to connect and learn about the latest technologies.
About us
Resource for bay area life scientists and biotech professionals to connect and learn about the latest technologies.
- Website
-
http://sfbn.org
External link for San Francisco Biotech Networks
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
Updates
-
SFBN Feed: Endpoints 11 winner MediLink Therapeutics: China startup helps power the ADC renaissance https://lnkd.in/gR9JVaYg ↑ CEO Tony Xue Total raised $120 million Headquarters Suzhou, China In the ADC renaissance of the last few years, Japan’s venerable pharma company Daiichi Sankyo has won many of the headlines. But if MediLink Therapeutics [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Endpoints 11 winner MediLink Therapeutics: China startup helps power the ADC renaissance
https://sfbn.org
-
SFBN Feed: Endpoints 11 winner Iambic Therapeutics: Entering the ‘show-me’ era for AI https://lnkd.in/gTF7iXJR ↑ CEO Tom Miller Total raised $220 million Headquarters San Diego, CA As two biotech rookies leaving long academic careers to co-found Iambic in 2019, CEO Tom Miller and CTO Fred Manby were “incredibly self-aware” of [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Endpoints 11 winner Iambic Therapeutics: Entering the ‘show-me’ era for AI
https://sfbn.org
-
SFBN Feed: Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers https://lnkd.in/gS46cP4B ↑ CEO Marc Tessier-Lavigne Total raised More than $1 billion in committed capital Headquarters South San Francisco, CA David Baker’s Seattle laboratory has become the place for the biopharma industry to push the limits of [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers
https://sfbn.org
-
SFBN Feed: Endpoints 11 winner Formation Bio: A Silicon Valley-fueled unicorn aiming to be the next Roivant — or more https://lnkd.in/gtABeutR ↑ CEO Benjamine Liu Total raised More than $600 million Headquarters New York, NY During his doctorate work at the University of Oxford, Benjamine Liu came across what he thought were some promising potential drugs for use [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Endpoints 11 winner Formation Bio: A Silicon Valley-fueled unicorn aiming to be the next Roivant — or more
https://sfbn.org
-
SFBN Feed: Alameda Health System receives Building Trust grant for patient house calls https://lnkd.in/gNF3RgVb OAKLAND, Calif., Sept. 26, 2024 /PRNewswire/ — Alameda Health System (AHS) has received a new grant that will help doctors offer home visits to patients. House calls are a model of care most often associated [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Alameda Health System receives Building Trust grant for patient house calls
https://sfbn.org
-
SFBN Feed: Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug https://lnkd.in/gCNDRE7n Why are Genentech’s cancer researchers concerned about the direction of the company? What led Pfizer to pull its sickle cell drug off global markets? And what cake did Adam make for all his podcast colleagues [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug
https://sfbn.org
-
SFBN Feed: Momentus Announces Proposed Settlement of Stockholder Derivative Action https://lnkd.in/gtVtf-ux SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers satellite buses, transportation, and other in‑space infrastructure services, today announced that the U.S. District Court for the [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Momentus Announces Proposed Settlement of Stockholder Derivative Action
https://sfbn.org
-
SFBN Feed: The Galien Foundation Announces 2024 Recipient of the Roy Vagelos, Pro Bono Humanum Award for Global Health Equity https://lnkd.in/gqKim6Yy – His Serene Highness Prince Albert II of Monaco to receive award on November 7, 2024, at the Prix Galien USA Awards Ceremony in New York City NEW YORK, Sept. 26, 2024 /PRNewswire/ — The [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
The Galien Foundation Announces 2024 Recipient of the Roy Vagelos, Pro Bono Humanum Award for Global Health Equity
-
SFBN Feed: Genentech’s blood cancer drug Gazyva moves toward more indications in immunology https://lnkd.in/gebrtXWf Genentech plans to expand the label for its CD20-targeting antibody Gazyva following positive late-stage data in an autoimmune disease that impacts the kidneys. In the Phase 3 REGENCY study, a higher proportion of patients with [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
Genentech’s blood cancer drug Gazyva moves toward more indications in immunology
https://sfbn.org